Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Marlex
FDA Approves DESVENLAFAXINE — Marlex Pharmaceuticals, Inc.

Marlex Pharmaceuticals, Inc. has secured final FDA approval for its desvenlafaxine succinate tablet, marking the company’s second serotonin norepineph...

Actavis
FDA Approves BOSENTAN — Actavis Pharma, Inc.

# FDA Approves Generic Bosentan The FDA has approved Actavis Pharma, Inc.'s generic formulation of bosentan (ANDA207110), a pulmonary arterial hypert...

Zydus
FDA Approves BOSENTAN — Zydus Pharmaceuticals USA Inc.

# FDA Approves Generic Bosentan The FDA has approved Zydus Pharmaceuticals USA Inc.'s generic formulation of bosentan, an endothelin receptor antagon...

AMNEAL
FDA Approves Unknown Drug — AMNEAL PHARMS CO

AMNEAL PHARMS CO. announced the FDA approval of its ANDA submission [Substance], broadening its product portfolio with a potential new entrant in the ...

Sun
FDA Approves BOSENTAN — Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical Industries, Inc. received approval for the ANDA209324 application for BOSENTAN (Generic: BOSENTAN), an oral treatment, on April 26,...

AbbVie
FDA Approves SKYRIZI — AbbVie Inc.

# FDA Approves AbbVie's SKYRIZI for Psoriasis Treatment AbbVie Inc. received FDA approval for SKYRIZI (risankizumab-rzaa), a subcutaneous IL-23 inhib...

SpecGx
FDA Approves MIXED SALTS OF A SINGLE ENTITY AMPHETAMINE PRODUCT XR — SpecGx LLC

SpecGx LLC today received FDA approval for its generic version of the ADHD drug Mixed Salts of a Single Entity Amphetamine Product XR, an event that s...

Dr.
FDA Approves TESTOSTERONE — Dr. Reddy's Laboratories, Inc.

Dr. Reddy’s Laboratories received FDA approval for its testosterone transdermal generic, a move that positions the company to expand its market share ...

Novartis
FDA Approves MAYZENT — Novartis Pharmaceuticals Corporation

On March 26, 2019, the U.S. FDA granted approval to Novartis Pharmaceuticals for Mayzent (siponimod), offering a new oral treatment option for adult p...

NorthStar
FDA Approves TADALAFIL — NorthStar RxLLC

NorthStar RxLLC announced today the FDA approval of Tadafil, a generic version of tadalafil with an ANDA 208934, to support the market with bioequival...

Micro
FDA Approves DALFAMPRIDINE — Micro Labs Limited

FDA has granted tentative approval to Micro Labs Limited for the generic version of dalfampridine tablets, introducing a cost-effective alternative to...

Eywa
FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Eywa Pharma Inc

Eywa Pharma Inc. has obtained FDA approval for its generic hydrocodone bitartrate and acetaminophen oral tablets, a regulatory milestone expected to b...

Genentech,
FDA Approves HERCEPTIN HYLECTA — Genentech, Inc.

Genentech, Inc. received FDA approval for Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) in early 2019, a formulation designed to significantl...

Rising
FDA Approves ABIRATERONE ACETATE — Rising Pharma Holdings, Inc.

Rising Pharma Holdings, Inc. announced the FDA’s February 25, 2019, approval of its oral Abiraterone Acetate drug, positioning the company to compete ...

Somerset
FDA Approves CISATRACURIUM BESYLATE — Somerset Therapeutics, LLC

Somerset Therapeutics received final FDA approval on February 20 to market cisatracurium besylate (ANDA 206791), positioning the company to capitalize...

HIBROW
FDA Approves Unknown Drug — HIBROW HLTHCARE

# FDA Approves ANDA for Hibrow Healthcare Hibrow Healthcare received FDA approval for an abbreviated new drug application (ANDA207863) on February 4,...

PAI
FDA Approves OXYCODONE HYDROCHLORIDE — PAI Holdings, LLC dba PAI Pharma

PAI Holdings, LLC dba PAI Pharma announced the approval of an abbreviated new drug application (ANDA206914) for OxyCODONE HYDROCHLORIDE oral dosage fo...

Alvogen
FDA Approves BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM — Alvogen Inc.

**LONDON --** AlvaPharma, a portfolio company of Aesica Pharmaceuticals, announced today the FDA approval of its buccal film formulation of buprenorph...

Organon
FDA Approves ONTRUZANT — Organon LLC

# FDA Approves Organon's ONTRUZANT (Trastuzumab) Biosimilar The FDA has approved Organon LLC's ONTRUZANT (trastuzumab), a biosimilar to Herceptin, ma...

INGENUS
FDA Approves Unknown Drug — INGENUS PHARMS LLC

On January 9, 2019, INGENUS PHARMS LLC received FDA approval for ANDA #210985, a move that positions the company to leverage significant market opport...